Upregulation of thymidine phosphorylase in chronic glomerulonephritis and its role in tubulointerstitial injury

Nephron - Clinical Practice

Volumn 102, Issue 3-4, 2006, Pages

  Wang, Eun Hui ^a   Yong, Bok Goh ^a   In, Sung Moon ^a   Cho, Hyun Park ^a   Lee, Kweon Heang ^a   Sung, Hak Kang ^a   Chang, Suk Kang ^a   Choi, Yeong Jin ^a,b  

^a The Catholic University of Korea   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

Chronic tubulointerstitial injury; Glomerulonephritis; Interstitial fibrosis; Microvessel density; Thymidine phosphorylase

Indexed keywords

MESSENGER RNA; THYMIDINE PHOSPHORYLASE;

ADULT; ANGIOGENESIS; ARTICLE; CELL INFILTRATION; CHRONIC GLOMERULONEPHRITIS; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DENSITY; ENZYME REGULATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOLOGY; IN SITU HYBRIDIZATION; INFLAMMATORY CELL; KIDNEY; KIDNEY FIBROSIS; KIDNEY INJURY; KIDNEY INTERSTITIUM; KIDNEY TUBULE; KIDNEY TUBULE CELL; MALE; MICROVASCULATURE; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

ADULT; CHRONIC DISEASE; DISEASE PROGRESSION; FEMALE; GLOMERULONEPHRITIS; HUMANS; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; THYMIDINE PHOSPHORYLASE; UP-REGULATION;

EID: 33344460145     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000089672     Document Type: Article

References (33)

1. Bohle A, Gise HV, Mackensen-Haen S, Stark-Jakob B: The obliteration of the postglomerular capillaries and its influence upon the function of both glomeruli and tubuli. Klin Wochenschr 1981;59:1043-1051.
2. Seron D, Alexopoulos E, Raftery MJ, et al: Number of interstitial capillary cross-sections assessed by monoclonal antibodies: relation to interstitial damage. Nephrol Dial Transplant 1990;5:889-893.
3. Mackensen-Haen S, Bohle A, Christensen J, et al: The consequences for renal function of widening of the interstitium and changes in the tubular epithelium of the renal cortex and outer medulla in various renal diseases. Clin Nephrol 1992;37:70-77.
4. Møller JC, Skriver E, Olsen S, Maunsbach AB: Ultrastructural analysis of human proximal tubules and cortical interstitium in chronic renal disease (hydronephrosis). Virchows Arch 1984;402:209-237.
5. Møller JC, Jørgensen TM, Mortensen J: Proximal tubular atrophy: qualitative and quantitative structural changes in chronic obstructive nephropathy in the pig. Cell Tissue Res 1986; 244:479-491.
6. Truong LD, Farhood A, Tasby J, Gillum D: Experimental chronic renal ischemia: Morphologic and immunologic studies. Kidney Int 1992;41:1676-1689.
7. Eddy AA: Molecular insights into renal interstitial fibrosis. J Am Soc Nephrol 1996;7: 2495-2508.
8. Iltzsch MH, el Kouni MH, Cha S: Kinetic studies of thymidine phosphorylase from mouse liver. Biochemistry 1985;19:6799-6807.
9. Brown NS, Bicknell R: Thymidine phosphorylase, 2-deoxy-D-ribose and angiogenesis. Biochem J 1998;334:1-8.
10. Miyazono K, Okabe T, Urabe A, et al: Purification and properties of an endothelial cell growth factor from human platelets. J Biol Chem 1987;262:4098-4103.
11. Ishikawa F, Miyazono K, Hellman U, et al: Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor. Nature 1989;338: 557-562.
12. Takahashi Y, Bucana CD, Liu W, et al: Platelet-derived endothelial cell growth factor in human colon cancer angiogenesis: role of infiltrating cells. J Natl Cancer Inst 1996;88: 1146-1151.
13. Waguri-Nagaya Y, Otsuka T, Sugimura I, et al: Synovial inflammation and hyperplasia induced by gliostatin/platelet-derived endothelial cell growth factor in rabbit knees. Rheumatol Int 2000;20:13-19.
14. Folkman J: What is the role of thymidine phosphorylase in tumor angiogenesis. J Natl Cancer Inst 1996;88:1091-1092.
15. Yoshimura A, Kuwazuru Y, Furukawa T, et al: Purification and tissue distribution of human thymidine phosphorylase: high expression in lymphocytes, reticulocytes and tumors. Biochem Biophys Acta 1990;1034:107-113.
16. Folkman J, Shing Y: Angiogenesis. J Biol Chem 1992;267:10931-10934.
17. Fox SB, Moghaddam A, Westwood M, Turley H, et al: Platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in normal tissues: an immunohistochemical study. J Pathol 1995;176:183-190.
18. Takeuchi M, Otsuka T, Matsui N, et al: Aberrant production of gliostatin/platelet-derived endothelial cell growth factor in rheumatoid synovium. Arthritis Rheum 1994;37:662-672.
19. Kasugai K, Joh T, Kataoka H, et al: Evidence for participation of gliostatin/platelet-derived endothelial cell growth factor in gastric ulcer healing. Life Sci 1997;61:1899-1906.
20. Creamer D, Jaggar R, Allen M, et al: Overexpression of the angiogenic factor platelet-derived endothelial cell growth factor/thymidine phosphorylase in psoriatic epidermis. Br J Dermatol 1997;137:851-855.
21. Okada K, Yokoyama K, Okihara K, et al: Immunohistochemical localization of platelet-derived endothelial cell growth factor expression and its relation to angiogenesis in prostate. Urology 2001;57:376-381.
22. Suzuki K, Morita T, Hashimoto S, Tokue A: Thymidine phosphorylase/ platelet-derived endothelial cell growth factor (PD-ECGF) associated with prognosis in renal cell carcinoma. Urol Res 2001;29:7-12.
23. Konda R, Sato H, Sakai K, et al: Expression of platelet-derived endothelial cell growth factor and its potential role in up-regulation of angiogenesis in scarred kidneys secondary to urinary tract diseases. Am J Pathol 1999;155:1587-1597.
24. Goto H, Kohno K, Sone S, et al: Interferon-dependent induction of thymidine phosphorylase/platelet-derived endothelial growth factor through activated sequence-like element in human macrophages. Cancer Res 2001;61:469-473.
25. Ishii R, Takiguchi N, Oda K, et al: Thymidine phosphorylase expression is useful in selecting adjuvant chemotherapy for stage III gastric cancer. Int J Oncol 2001;19:717-722.
26. Choi YJ, Chakraborty S, Nguyen V, et al: Peritubular capillary loss is associated with chronic tubulointerstitial injury in human kidney: altered expression of vascular endothelial growth factor. Hum Pathol 2000;31:1491-1497.
27. Folkman J, Cortran R: Relation of vascular proliferation to tumor growth. Int Rev Exp Pathol 1976;16:207-248.
28. Polverini PJ, Cotran PS, Gimbrone MA Jr, Unanue ER: Activated macrophages induce vascular proliferation. Nature 1977;269:804-806.
29. Majno G: Chronic inflammation: links with angiogenesis and wound healing. Am J Pathol 1998;153:1035-1039.
30. Ooi BS, MacCarthy EP, Hsu A, Ooi YM: Human mononuclear cell modulation of endothelial cell proliferation. J Lab Clin Med 1983; 102:428-433.
31. Polverini PJ, Leibovich SJ: Induction of neovascularization in vivo and endothelial proliferation in vitro by tumor-associated macrophages. Lab Invest 1984;51:635-642.
32. Eda H, Fujimoto K, Watanabe S, et al: Cytokines induce thymidine phosphorylase expression in tumor cells and make them more susceptible to 5′-deoxy-5-fluorouridine. Cancer Chemother Pharmacol 1993;32:333-338.
33. Duk-Hee Kang, Richard J: Johnson: Vascular endothelial growth factor: A new player in the pathogenesis of renal fibrosis. Curr Opin Nephrol Hypertens 2003;12:43-49.